Only the infection + vaccination group displayed anti-RBD IgA levels that remained higher than the infection-only group when marginalized over the course of follow-up; on average, levels were 2.6 (95% CI: 2.1–3.1) times higher (Table S3). This evidence concerns the gene CD79A and infection.